Do chemokines spark autoimmunity in juvenile and adult rheumatic disease?

Immunobiology

Volumn 206, Issue 4, 2002, Pages 459-471

  Mangge, Harald ^a   Vojinovic, Jelena ^b   Schauenstein, Konrad ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b University Hospital Nis   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CYTOKINE; CYTOKINE ANTIBODY; DNA; FRACTALKINE; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; AUTOIMMUNITY; BIOLOGICAL MODEL; CHILD; HUMAN; IMMUNOLOGY; JUVENILE RHEUMATOID ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; ALLELE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; BASOPHIL DEGRANULATION; CELL INTERACTION; CELL MIGRATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; DRUG TARGETING; IMMUNE RESPONSE; LYMPHOCYTE HOMING; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PANNUS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RHEUMATIC DISEASE; SYNOVIAL FLUID; T LYMPHOCYTE ACTIVATION;

ADULT; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; CHEMOKINES; CHILD; HUMANS; MODELS, IMMUNOLOGICAL; RECEPTORS, CHEMOKINE;

EID: 0036775537     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00194     Document Type: Article

References (75)

1. ROLLINS, JR. 1997. Chemokines. Blood 90: 909.
2. KENNEDY, J., G. KELNER, S. KLEYENSTEUBER, T. SCHALL, M.WEISS, H. YSSEL., P.SCHNEIDER, B.COCKS, K. BACON, and A. ZLOTNIK. 1995. Molecular cloning and functional characterization of human lymphotactin. J. Immunol. 155: 203.
3. HUANG, H., F. LI, C. M. CAIRNS, J. R. GORDON, and J. XIANG. 2001. Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin. Biochem. Biophys. Res. Commun. 281: 378.
4. BAZAN, J. F., K. B. BACON, G. HARDIMAN, W. WANG, K. SOO, D. ROSSI, D. R. GREAVES, A. ZLOTNIK, and T. J. SCHALL. 1997. A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640.
5. GUNN, M. D., V. N. NGO, K. M. ANSEL, E. H. EKLAND, J. G. CYSTER, and L. T. WILLIAMS. 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391: 799.
6. MELLADO, M., J. M. RODRIGUEZ-FRADE, S. MANES, and A. C. MARTINEZ. 2001. Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu. Rev. Immunol. 19: 397.
7. HOLTMANN, H., J. ENNINGA, S. KALBLE, A. THIEFES, A. DORRIE, M. BROEMER, R. WINZEN, A. WILHELM, J. NINOMIYA-TSUJI, K. MATSUMOTO, K. RESCH, and M. KRACHT. 2001. The MAPK kinase TAK1 plays a central role in coupling the interleukin-1 receptor to both transcriptional and RNA-targeted mechanisms of gene regulation. J. of Biol. Chem. 276: 3508.
8. YONEZAWA, A., T. HORI, H. SAKAIDA, and T. UCHIYAMA. 2000. SDF-1 has costimulatory effects on human T cells: possible involvement of MAPK (ERK2) activation. Microbiol. Immunol. 44: 135.
9. RUMSEY, L. M., R. M. TEAGUE, S. H. BENEDICT, and M. A. CHAN. 2001. MIP-1alpha induces activation of phosphatidylinositol-3 kinase that associates with Pyk-2 and is necessary for B-cell migration. Exp. Cell Res. 268: 77.
10. LOETSCHER, M., B. GERBER, P. LOETSCHER, S. A. JONES, L. PIALI, I. CLARK-LEWIS, M. BAGGIOLINI, and B. MOSER. 1996. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T lymphocytes. J. Exp. Med. 184: 963.
11. LOETSCHER, P., M. SEITZ, M. BAGGIOLINI, and B. MOSER. 1996. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T Lymphocytes. J. Exp. Med. 184: 569.
12. LOETSCHER, P., M. UGUCCIONI, L. BORDOLI, M. BAGGIOLINI, B. MOSER, C. CHIZZOLINI, and J. M. DAYER. 1998. CCR5 is characteristic for Th1 lymphocytes. Nature 391: 344.
13. MACKAY, C. R. 2001. Chemokines: immunology's high impact factors. Nature Immunol. 2: 95.
14. HEDRICK, J. A., and A. ZLOTNIK. 1996. Chemokines and lymphocyte biology. Curr. Opin. Immunol. 8: 343.
15. HEDRICK, J. A., V. SAYLOR, D. FIGUEROA, L. MIZOE, Y. XU, S. MENON, J. ABRAMS, T. HANDEL, and A. ZLOTNIK. 1997. Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J. of Immunol. 158: 1533.
16. SMITH, R. J., L. M. SAM, K. L. LEACH, and J. M. JUSTEN. 1992. Postreceptor events associated with human neutrophil activation by interleukin-8. J. of Leukoc. Biol. 52: 17.
17. FUJIKURA, T., and H. OTSUKA. 1998. Monocyte chemotactic and activating factor/monocyte chemoattractant protein-1-mediated histamine release from human nasal mucosa. Arch. Otolaryngol. Head Neck Surg. 124: 1331.
18. VAN COILLIE, E., I. VAN AELST, A. WUYTS, R. VERCAUTEREN, R. DEVOS, C. DE WOLF-PEETERS, J. VAN DAMME, and G. OPDENAKKER. 2001. Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle. Am. J. of Pathol. 159: 1405.
19. VOLIN, M. V., J. M. WOODS, M. A. AMIN, M. A. CONNORS, L. A. HARLOW, and A. E. KOCH. 2001. Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. Am. J. of Pathol. 159: 1521.
20. PALMER, K., M. HITT, P. C. EMTAGE, S. GYORFFY, and J. GAULDIE. 2001. Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity. Gene Ther. 8: 282.
21. KUNKEL, E. J., J. J. CAMPBELL, G. HARALDSEN, J. PAN, J. BOISVERT, A. I. ROBERTS, E. C. EBERT, M. A. VIERRA, S. B. GOODMAN, M. C. GENOVESE, A. J. WARDLAW, H. B. GREENBERG, C. M. PARKER, E. C. BUTCHER, A. P. ANDREW, and W. W. AGACE. 2000. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J. Exp. Med. 192: 761.
22. LEE, S. C., M. E. BRUMMET, S. SHAHABUDDIN, T. G. WOODWORTH, S. N. GEORAS, K. M. LEIFERMAN, S. C. GILMAN, C. STELLATO, R. P. GLADUE, R. P. SCHLEIMER, and L. A. BECK. 2000. Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes. J. of Immunol. 164: 3392.
23. + T lymphocytes with regulatory activity. J. of Immunol. 166: 996.
24. FORSTER, R., A. E. MATTIS, E. KREMMER, E.WOLF, G. BREM, and M. LIPP. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87: 1037.
25. MANTOVANI, A., P. ALLAVENA, A. VECCHI, and S. SOZZANI. 1998. Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses. Int. J. of Clin. Lab. Res. 28: 77.
26. CAMPBELL, J. D., and K. T. HAYGLASS. 2000. T cell chemokine receptor expression in human Th1- and Th2- associated diseases. Arch. Immunol. Ther. Exp. (Warsz) 48: 451.
27. KARPUS, W J., and K. J. KENNEDY. 1997. Mip-1 alpha and Mcp-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J. of Leuco. Biol. 62: 681.
28. KARPUS, W J., N. W. LUKACS, K. J. KENNEDY, W. S. SMITH, S. D. HURST, and T. A. BARRETT. 1997. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. of Immunol. 158: 4129.
29. KARPUS, W. J., K. J. KENNEDY, S. L. KUNKEL, and N. W. LUKACS. 1998. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J. of Exp. Med. 187: 733.
30. BACON, K. B., B. A. PREMACK, P. GARDNER, and T. J. SCHALL. 1995. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269: 1727.
31. FIRESTEIN, G. S. 1996. Invasive fibroblast-like synoviocytes in rheumatoid arthritis passive responders to transformed aggressors? Arthritis Rheum. 39: 1781.
32. BRESNIHAN, B. 1999. Pathogenesis of joint damage in rheumatoid arthritis. J. of Rheumatol. 26: 717.
33. ALLARD, S. A., K. D. MUIRDEN, K. L. CAMLEJOHN, and R. N. MAINI. 1987. Chondrocyte derived cells and matrix at the rheumatoid cartilage-pannus junction identified with monoclonal antibodies. Rheumatol. Int. 7: 153.
34. KONTTINEN, Y. T., T. SALO, R. HANEMAAIJER, H. VALLEALA, T. SORSA, M. SUTINEN, A. CEPONIS, J. W. XU, S. SANTAVIRTA, O. TERONEN, and C. LOPEZ-OTIN. 1999. Collagenase-3 (MMP-3) and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate. Matrix Biol. 18: 401.
35. FELDMANN, M., and R. N. MAINI. 1999. The role of cytokines in the pathogenesis of rheumatoid arthritis. Rheumatology Oxford 38(Suppl): 23.
36. SMOLEN, J. S., M. TOHIDAST-AKRAD, A. GAL, M. KUNAVER, G. EBERL, P. ZENZ, A. FALUS, and G. STEINER. 1996. The role of T-lymphocytes and cytokines in rheumatoid arthritis. Scand. J. of Rheumatol. 25: 1.
37. VAN ROON, J., F. LAFEBER, and J. BIJLSMA. 2001. Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum. 44: 3.
38. MANGGE, H., P. FELSNER, J. HERRMANN, Y. EL-SHABRAWI, P. LIEBMANN, and K. SCHAUENSTEIN. 1999. Early rheumatoid arthritis is associated with diminished numbers of TH1 cells in stimulated peripheral blood. Immunobiology 200: 290.
39. HOSAKA, S., T. AKAHOSHI, C. WADA, and H. KONDO. 1994. Expression of the chemokine superfamily in rheumatoid arthritis. Clin. Exp. Immunol. 97: 451.
40. MANGGE, H., and K. SCHAUENSTEIN. 1998. Cytokines in juvenile rheumatoid arthritis. Cytokine 10: 471.
41. LUSTER, A. D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. of Med. 338: 436.
42. PATEL, D. D., J. P. ZACHARIAH, and L. P. WHICHARD. 2001. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin. Immunol. 98: 39.
43. QIN, S., J. B. ROTTMAN, P. MYERS, N. KASSAM, M. WEINBLATT, M. LOETSCHER, A. E. KOCH, B. MOSER, and C. R. MACKAY. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. of Clin. Invest. 101: 746.
44. BUCKLEY, C. D., N. AMFT, P. F. BRADFIELD, D. PILLING, E. ROSS, F. ARENZANA-SEISDEDOS, A. AMARA, S. J. CURNOW, J. M. LORD, D. SCHEEL-TOELLNER, and M. SALMON. 2000. Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J. of Immunol. 165: 3423.
45. NANKI, T., K. HAYASHIDA, H. S. EL-GABALAWAY, S. SUSON, K. SHI, H. Y. GIRSCHICK, S. YAVUZ, and P. E. LIPSKY. 2000. Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid synovium. J. of Immunol. 165: 6590.
46. SUZUKI, N., A. NAKAJIMA, S. YOSHINO, K. MATSUSHIMA, H. YAGITA, AND K. OKUMURA. 1999. Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int. Immunol. 11: 553.
47. CHAPMAN, G. A., K. E. MOORES, J. GOHIL, T. A. BERKHOUR, L. PATEL, P. GREEN, C. H. MACPHEE, and B. R. STEWART. 2000. The role of fractalkine in the recruitment of monocytes to the endolthelium. Eur. J. of Pharmacol. 392: 189.
48. rd, D. C. WOODRUFF, K. J. KATSCHKE JR, J. M. WOODS, C. C. PARK, J. C. MOREL, and A. E. KOCH. 2001. Fracalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum. 44: 1568.
49. KATSCHKE, K. J. JR, J. B. ROTTMAN, J. H. RUTH, S. QIN, L. WU, G. LAROSA, P. PONATH, C. C.PARK, R. M. POPE, and A. E. KOCH. 2001. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum. 44: 1022.
50. KOCH, A., M. VOLIN, J. WOODS, S. KUNKEL, M. CONNORS, L. HARLOW, D. WOODRUFF, M. BURDICK, and R. STRIETER. 2001. Regulation of angiogenesis by the C-X-C Chemokines Interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint. Arthritis Rheum. 44: 31.
51. SZEKANECZ, Z., and A. E. KOCH. 2001. Chemokines abnd angiogenesis. Curr. Opin. Rheumatol. 13: 202.
52. LISIGNOLI, G., S. TONEGUZZI, C. POZZI, A. PIACENTINI, M. RICCIO, A. FERRUZZI, G. GUALTIERI, and A. FACCHINI. 1999. Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteorarthritis. J. of Rheumatol. 26: 791.
53. BORZI, R. M., I. MAZZETTI, S. MACOR, T. SILVESTRI, A. BASSI, L. CATTINI, and A. FACCHINI. 1999. Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis. FEBS Lett. 455: 238.
54. ROTHE, L., P. COLLIN-OSDOBY, Y. CHEN, and T. SUNYER, L. CHAUDHARY, A. TSAY, S. GOLDRING, L. AVIOLI, and P. OSDOBY. 1998. Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8,. Endocrinology 139: 4353.
55. MANGGE, H., H. KENZIAN, S. GALLISTL, G. NEUWIRTH, W. KAULFERSCH, F. BEAUFORT, W. MUNTEAN, and K. SCHAUENSTEIN. 1995. Serum cytokines in juvenile rheumatoid arthritis (JRA). Correlation with conventional inflammatory parameters and clinical subtypes. Arthritis Rheum. 38: 211.
56. DE-BENEDETTI, F., P. PIGNATTI, S. BERNASCONI, V. GERLONI, K. MATSUSHIMA, R. CAPORALI, C. M. MONTECUCCO, S. SOZZANI, F. FANTINI, and A. MARTINI. 1999. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes. J. of Rheumatol. 26: 425.
57. DONN, R. P., E. SHELLEY, W. E. OLLIER, and W. THOMSON. 2001. A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 44: 1782.
58. KHALKHALI-ELLIS, Z., G. A. BULLA, L. S. SCHLESINGER, D. A. KIRSHMAN, T. L. MOORE, and M. J. HENDRIX. 1999. Clq containing immune complex purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: Role of Clq receptors. J. of Immunol. 163: 4612.
59. WEDDERBURN, L. R., N. ROBINSON, A. PATEL, H. VARSANI, and P. WOO. 2000. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflammed joints of children with juvenile idiopathic arthritis. Arthritis Rheum. 43: 765.
60. + T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL4:IFN-gamma mRNA ratios. J. of Immunol. 166: 6899.
61. SZEKANECZ, Z., M. M. HALLORAN, M. V. VOLIN, J. M. WOODS, R. M. STRIETER, G KENNETH HAINES 3rd, S. L. KUNKEL, M. D. BURDICK, and A. E. KOCH. 2000. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis Rheum. 43: 1266.
62. THORNTHON, S., L. E. DUWEL, G. P. BOIVIN, Y. MA, and R. HIRSCH R. 1999. Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression. Arthritis Rheum. 42: 1109.
63. KRAAN, M. C., H. VERSENDAAL, M. JONKER, B. BRESNIHAN, W. J. POST, B. A. T HART, F. C. BREEDVELD, and P. P. TAK. 1998. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum. 41: 1481.
64. MARTINEZ-MARTINEZ, C. M., and R. HERNANDEZ-PANDO. 1999. Chemokines, a new family of cytokines in inflammatory cell recruitment. Rev. Invest. Clin. 51: 255.
65. KATRIB, A., P. P. TAK, J. V. BERTOUCH, C. CUELLO, H. P. MCNEIL, T. J. SMEETS, M. C. KRAAN, and P. P. YOUSSEF. 2001. Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis. Rheumatology-(Oxford) 40: 988.
66. ZAPICO, I., E. COTO, A. RODRIGUEZ, C. ALVAREZ, J. C. TORRE, and V. ALVAREZ. 2000. CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun. 1: 288.
67. NAYA, A., Y. SAGARA, K. OHWAKI, T. SAEKI, D. ICHIKAWA, Y. IWASAWA, K. NOGUCHI, and N. OHTAKE. 2001. Design, synthesis, and discovery of a novel CCR1 antagonist. J. of Med. Chem. 44: 1429.
68. LUGERING, N., T. KUCHARAZIK, C. MAASER, M. KRAFT, and W. DOMSCHKE. 1999. Interleukin-15 strongly inhibits interleukin-8 and monocyte chemoattractant protein-1 production in human colonic epithelial cells. Immunology 98: 504.
69. BADOLATO, R., A. N. PONZI, M. MILLESIMO, L. D. NOTARANGELO, and T. MUSSO. 1997. Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes. Blood 90: 2804.
70. KOTAKE, S., H. R. SCHUHMACHER, C. H. YARBORO, T. K. ARAYSSI, J. A. PANDO, K. S. KANIK, M. F. GOURLEY, J. H. KLIPPEL, and R. L. WILDER. 1997. In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis. Proc. Assoc. Am. Physicians 109: 286.
71. PEEVA, E., A. D. FISHMAN, G. GODDARD, S. WADLER, and P. BARLAND. 2000. Rheumatoid arthritis exacerbation caused by exogenous interleukin-12. Arthritis Rheum. 43: 461.
72. BALASHOV, K. E., J. B. ROTTMAN, H. L. WEINER, and W. W. HANCOCK. 1999. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Nat. Acad. Sci. USA 96: 6873.
73. BRENNAN, F. M. 2001. A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" by Wim B van den Berg. Arthritis Res. 3: 211.
74. VAN DEN BERG, W. B. 2001. Anti-cytokine therapy in chronic destructive arthritis. Arthritis Res. 3: 18.
75. GARRED, P., H. O. MADSEN, J. PETERSEN, H. MARQUART, T. M. HANSEN, S. FREIESLEBEN-SORENSEN, B. VOLCK, A. SVEJGAARD, and V. ANDERSEN. 1998. CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J. of Rheumatol. 25: 1462.